Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q3

4521.TEDINET S100SS78
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥54.7bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥73.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥55.6bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥8.9bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥12.4bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥9.3bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥8.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.0bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥9.2bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥12.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥6.7bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.1bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥6.7bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥9.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥168.3bnat 2023-12-31Cons.Assets
Total assets¥166.3bnat 2023-03-31Cons.Assets
Total assets¥167.8bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥28.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥29.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥140.1bnat 2023-12-31Cons.Net assets
Net assets / equity¥136.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥140.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥51.5bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥59.6bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥177.12023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.852023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.82022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥243.312022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥84.992022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio83.2%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.5%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-12-31¥52.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-12-31¥52.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-12-31¥7.9bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-12-31¥1.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥54.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥54.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥8.9bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-12-31¥53.8bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-12-31¥53.8bn
jpcrp040300-q3r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-12-31¥11.4bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-12-31¥960m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥55.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥55.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥12.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 380
ItemContextValueUnit
Short term loans payablePrior1YearInstant3850000000JPY
Short term loans payableCurrentQuarterInstant3850000000JPY
Income taxes payablePrior1YearInstant2004000000JPY
Income taxes payableCurrentQuarterInstant825000000JPY
Provision for bonusesPrior1YearInstant942000000JPY
Provision for bonusesCurrentQuarterInstant461000000JPY
Other clPrior1YearInstant7822000000JPY
Other clCurrentQuarterInstant6129000000JPY
Current liabilitiesPrior1YearInstant20838000000JPY
Current liabilitiesCurrentQuarterInstant19550000000JPY
Provision for share based remuneration nclPrior1YearInstant117000000JPY
Provision for share based remuneration nclCurrentQuarterInstant85000000JPY
Net defined benefit liabilityPrior1YearInstant6349000000JPY
Net defined benefit liabilityCurrentQuarterInstant6347000000JPY
Deferred tax liabilitiesPrior1YearInstant1771000000JPY
Deferred tax liabilitiesCurrentQuarterInstant1771000000JPY
Other nclPrior1YearInstant414000000JPY
Other nclCurrentQuarterInstant445000000JPY
Noncurrent liabilitiesPrior1YearInstant8653000000JPY
Noncurrent liabilitiesCurrentQuarterInstant8650000000JPY
LiabilitiesPrior1YearInstant29491000000JPY
LiabilitiesCurrentQuarterInstant28200000000JPY
Capital stockPrior1YearInstant23853000000JPY
Capital stockCurrentQuarterInstant23853000000JPY
Capital surplusPrior1YearInstant11406000000JPY
Capital surplusCurrentQuarterInstant11462000000JPY
Retained earningsPrior1YearInstant126135000000JPY
Retained earningsCurrentQuarterInstant127155000000JPY
Treasury stockPrior1YearInstant-30026000000JPY
Treasury stockCurrentQuarterInstant-28613000000JPY
Shareholders equityPrior1YearInstant131368000000JPY
Shareholders equityCurrentQuarterInstant133858000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant4724000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant6117000000JPY
Remeasurements of defined benefit plansPrior1YearInstant165000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant161000000JPY
Valuation and translation adjustmentsPrior1YearInstant4889000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant6278000000JPY
Non controlling interestsPrior1YearInstant578000000JPY
Non controlling interestsCurrentQuarterInstant－JPY
Net assetsPrior1YearInstant136836000000JPY
Net assetsCurrentQuarterInstant140137000000JPY
Liabilities and net assetsPrior1YearInstant166328000000JPY
Liabilities and net assetsCurrentQuarterInstant168337000000JPY
Net salesPrior1YTDDuration55573000000JPY
Net salesCurrentYTDDuration54685000000JPY
Cost of salesPrior1YTDDuration25010000000JPY
Cost of salesCurrentYTDDuration24825000000JPY
Gross profitPrior1YTDDuration30562000000JPY
Gross profitCurrentYTDDuration29860000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass